National Breast Cancer Coalition

Public Policy

Breast cancer is a political issue. The federal government is the largest funder of biomedical research. Laws regulate and support access to care and health care systems. Third party payors are subject to state and federal regulations. In fact, every aspect of breast cancer is touched by public policy. It is key that those who influence that policy are educated and trained and have no agenda other than to save lives, and to end breast cancer.

To ensure this, NBCC informs, trains and directs patients and others in effective advocacy efforts. Nationwide, the women and men we have trained are shaping breast cancer public policy by participating in legislative, scientific and regulatory decisions; promoting critical analysis of breast cancer information and media coverage; and actively working to change all systems that impact our Breast Cancer Deadline 2020® mission to know how to end breast cancer by January 1, 2020.

National Breast Cancer Coalition
2018 Legislative and Public Policy Priorities

Legislative Priorities 
PRIORITY #1:

$150 Million for the Department of Defense (DOD) Breast Cancer Research Program (BCRP) for FY2019: As a result of NBCC’s grassroots advocacy, the DOD BCRP was created in 1992 to “eradicate breast cancer by funding innovative, high-impact research through a partnership of scientists and consumers.”  The DOD BCRP is widely viewed as an innovative, unique, and efficient medical research model which has proven to be accountable to the public and has produced extraordinary results.  NBCC seeks continued funding for this successful program.

PRIORITY #2:

A bill to waive the 24 month waiting period for Medicare eligibility and the 5 month waiting period for Social Security Disability Insurance benefits for individuals with Metastatic Breast Cancer. This legislation would waive all waiting periods for Medicare eligibility and Social Security Disability Insurance (SSDI) eligibility on the basis of disability for individuals with metastatic breast cancer and provide Medicare health care coverage including drugs and biologicals and all interventions used for the treatment and alleviation of symptoms relating to metastatic breast cancer.

PRIORITY #3:

Preservation of the Medicaid Breast and Cervical Cancer Treatment Program: Congress enacted the Breast and Cervical Cancer Treatment Act in 2000 after years of NBCC grassroots lobbying and influence.  NBCC remains committed to ensuring all women and men screened and diagnosed with breast cancer through federal screening programs have access to the treatment they need.

Public Policy Priorities
PRIORITY #1:

Guaranteed Access to Quality Care for All: Ensuring access to quality, evidence-based health care has been a top priority of NBCC for many years and is an essential component of Breast Cancer Deadline 2020®. Prior to the passage of the Affordable Care Act (ACA), the NBCC grassroots Board of Directors approved a Framework for a Health Care System Guaranteeing Access to Quality Health Care for All which built on NBCC’s Principles for Quality Care. In 2010, NBCC endorsed and advocated for the passage and implementation of ACA which marked important steps forward in access to quality health care for individuals with, and at risk of, breast cancer. The Coalition opposes and will work to defeat any and all efforts to repeal the ACA or replace it with something less expansive.

PRIORITY #2:

Ensuring the Participation of Educated Patient Advocates in Science Research and all Levels of Health Care Decision Making: NBCC continues to work to ensure that educated patient advocates who represent a constituency, have a meaningful “seat at the table” in all levels of health care decision making which affects their lives.